Ann: Sharewise Investor Presentation, page-10

He also refused to elaborate, and actually avoided the question about competition, but lauded the safety of MSC technology.

We already know that, from the Companies that have done testing on naturally derived MSC's, and are near to approval.

What KK failed to discuss was the "ugly" term, reproducing artificial cells, or reproducing cells artificially for the greenies.

The question remains the same about manufactured cells in vitro attempted replication.

It is simply many years away to prove that science when the FDA are just getting their head around the benefits of naturally derived cell technology, or should I say the worlds demand for it already.